CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4/A Grant or award Director acquired 2,945 shares (grant or award)
- 4 Planned sale General Counsel sold 2,000 shares at $38.47 ($76,940)
- 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at an average $39.06 ($650,952)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Planned sale GOLDSMITH MARK A sold 11,950 shares at $37.39 ($446,770)
- 4 Planned sale Chief Financial Officer sold 1,893 shares at $37.39 ($70,775)
- 4 Planned sale Chief Operating Officer sold 4,415 shares at $37.39 ($165,064)
- 4 Planned sale Kelsey Stephen Michael sold 3,349 shares at $37.39 ($125,209)
- 4 Planned sale General Counsel sold 1,757 shares at $37.39 ($65,690)
- 4 Open-market sale Chief Medical Officer sold 5,589 shares at $37.39 ($208,954)
- 4 Planned sale GOLDSMITH MARK A sold 7,500 shares at an average $39.99 ($299,942)
- 4 Planned sale General Counsel sold 1,500 shares at an average $39.11 ($58,671)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $40.03 ($400,260)
- 4 Planned sale GOLDSMITH MARK A sold 17,500 shares at an average $35.40 ($619,467)
Page 9 of 21 · 414 filings